Biodesix Inc cash flow statement
In fiscal 2025, Biodesix Inc's operations generated −$23.3m of cash; it spent $259,000 on capital projects, leaving free cash flow of −$23.5m.
Cash flow statement
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −22 | −21 | −28 | −45 | −23 | −49 | −23 | −20 |
| Depreciation and amortisation | 3 | 3 | 3 | 4 | 3 | 6 | 6 | 6 |
| Stock-based pay | 0 | 4 | 5 | 6 | 5 | 7 | 4 | 4 |
| Capital spending | 1 | 2 | 2 | 3 | 23 | 3 | 0 | 0 |
| Free cash flow | −23 | −23 | −30 | −48 | −46 | −52 | −24 | −20 |
| Free cash flow after stock pay | −23 | −27 | −35 | −54 | −51 | −59 | −28 | −24 |
| Shares issued | — | — | 16 | 60 | 28 | 56 | 7 | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −11 | −4 | −9 | −7 | −9 | 1 | −10 | −2 |
| Depreciation and amortisation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Stock-based pay | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Capital spending | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −11 | −5 | −9 | −7 | −9 | 1 | −10 | −2 |
| Free cash flow after stock pay | −12 | −6 | −10 | −8 | −10 | −0 | −11 | −3 |
| Shares issued | 0 | 0 | — | — | — | 2 | 17 | 7 |
Compare with peers
- Mdxhealth SA cash flow
- Harvard Bioscience Inc cash flow
- Codexis, Inc. cash flow
- Burning Rock Biotech Ltd cash flow
- Exagen Inc. cash flow
Head to head: BDSX vs MDXHBDSX vs HBIOBDSX vs CDXS
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies